These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17194818)

  • 41. ECT-donepezil interaction: a single case report.
    Bhat RS; Mayur P; Chakrabarti I
    Int J Geriatr Psychiatry; 2004 Jun; 19(6):594-5. PubMed ID: 15211544
    [No Abstract]   [Full Text] [Related]  

  • 42. How to manage overactive bladder in elderly individuals with dementia? A combined use of donepezil, a central acetylcholinesterase inhibitor, and propiverine, a peripheral muscarine receptor antagonist.
    Sakakibara R; Ogata T; Uchiyama T; Kishi M; Ogawa E; Isaka S; Yuasa J; Yamamoto T; Ito T; Yamanishi T; Awa Y; Yamaguchi C; Takahashi O
    J Am Geriatr Soc; 2009 Aug; 57(8):1515-7. PubMed ID: 19682155
    [No Abstract]   [Full Text] [Related]  

  • 43. Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation.
    Anzellotti F; Bonanni L; Iorio E; Di Baldassarre F; D'Andreagiovanni A; Monaco D; Thomas A; Onofrj M
    Clin Neuropharmacol; 2008; 31(4):231-7. PubMed ID: 18670247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
    Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
    [No Abstract]   [Full Text] [Related]  

  • 45. Intraoperative floppy-iris syndrome associated with chronic intake of donepezil.
    Papadopoulos R; Bachariou A
    J Cataract Refract Surg; 2007 Nov; 33(11):1997-8. PubMed ID: 17964415
    [No Abstract]   [Full Text] [Related]  

  • 46. Pisa syndrome caused by an acetylcholinesterase inhibitor in a patient with dementia with Lewy bodies.
    Shinfuku M; Nakajima S; Uchida H; Watanabe K; Kocha H; Kashima H
    Psychiatry Clin Neurosci; 2011 Apr; 65(3):299. PubMed ID: 21507139
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer's disease.
    Tei E; Yamamoto H; Watanabe T; Miyazaki A; Nakadate T; Kato N; Mimura M
    Growth Horm IGF Res; 2008 Feb; 18(1):47-54. PubMed ID: 17714966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A; Gauthier S; Perdomo C
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severe worsening of parkinsonism in Lewy body dementia due to donepezil.
    Rozzini L; Ghianda D; Trabucchi M; Padovani A
    Neurology; 2004 Oct; 63(8):1543-4; author reply 1543-4. PubMed ID: 15505196
    [No Abstract]   [Full Text] [Related]  

  • 50. Occupational contact urticaria caused by donepezil.
    Galvez Lozano JM; Alcantara M; De San Pedro BS; Quiralte J; Caba I
    Contact Dermatitis; 2009 Sep; 61(3):176. PubMed ID: 19780775
    [No Abstract]   [Full Text] [Related]  

  • 51. Impairment of decision-making cognition in a case of frontotemporal lobar degeneration (FTLD) presenting with pathologic gambling and hoarding as the initial symptoms.
    Nakaaki S; Murata Y; Sato J; Shinagawa Y; Hongo J; Tatsumi H; Mimura M; Furukawa TA
    Cogn Behav Neurol; 2007 Jun; 20(2):121-5. PubMed ID: 17558256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrence of upper gastrointestinal bleeding after donepezil administration.
    Cholongitas E; Pipili C; Dasenaki M
    Alzheimer Dis Assoc Disord; 2006; 20(4):326. PubMed ID: 17132985
    [No Abstract]   [Full Text] [Related]  

  • 53. Possible association between donepezil and worsening Parkinson's disease.
    Bourke D; Druckenbrod RW
    Ann Pharmacother; 1998 May; 32(5):610-1. PubMed ID: 9606486
    [No Abstract]   [Full Text] [Related]  

  • 54. [A reply to Pfizer: Still no reason to change SBU's conclusions on drugs against dementia].
    Edhag O; Norlund A
    Lakartidningen; 2007 Jan 10-16; 104(1-2):55. PubMed ID: 17323745
    [No Abstract]   [Full Text] [Related]  

  • 55. A 6-month, open-label study of memantine in patients with frontotemporal dementia.
    Diehl-Schmid J; Förstl H; Perneczky R; Pohl C; Kurz A
    Int J Geriatr Psychiatry; 2008 Jul; 23(7):754-9. PubMed ID: 18213609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?
    Tinklenberg JR; Kraemer HC; Yaffe K; Ross L; Sheikh J; Ashford JW; Yesavage JA; Taylor JL
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):953-60. PubMed ID: 17974866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Donepezil: syncope. Various cardiac disorders.
    Prescrire Int; 2008 Jun; 17(95):113. PubMed ID: 18630357
    [No Abstract]   [Full Text] [Related]  

  • 58. Frontotemporal dementia: a clinically complex diagnosis.
    Rosness TA; Haugen PK; Passant U; Engedal K
    Int J Geriatr Psychiatry; 2008 Aug; 23(8):837-42. PubMed ID: 18302319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Dementia of trisomy 21. Improvement with donepezil].
    Schill D
    Med Monatsschr Pharm; 2005 Oct; 28(10):371-2. PubMed ID: 16245462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.